Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study.

Saved in:
Bibliographic Details
Title: Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study.
Authors: Okamoto K; Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan., Saito Y; Faculty of Pharmaceutical Sciences, Department of Clinical Pharmaceutics and Therapeutics, Hokkaido University of Science, 4-1, Maeda 7-Jo 15-Chome, Teine-Ku, Sapporo, 006-8585, Japan. yossypma@med.hokudai.ac.jp., Takahashi K; Department of Pharmacy, NTT Medical Center Sapporo, Minami 1-Jo, Nishi 15-Chome, Chuo-Ku, Sapporo, 060-0061, Japan., Takekuma Y; Department of Pharmacy, Hokkaido University Hospital, Kita-14-Jo, Nishi-5-Chome, Kita-Ku, Sapporo, 060-8648, Japan., Sakakibara-Konishi J; Faculty of Medicine, Department of Respiratory Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan., Narumi K; Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.; Faculty of Pharmaceutical Sciences, Education Research Center for Clinical Pharmacy, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan., Sugawara M; Department of Pharmacy, Hokkaido University Hospital, Kita-14-Jo, Nishi-5-Chome, Kita-Ku, Sapporo, 060-8648, Japan.; Faculty of Pharmaceutical Sciences, Laboratory of Pharmacokinetics, Hokkaido University, Kita 12-Jo, Nishi 6-Chome, Kita-Ku, Sapporo, 060-0812, Japan., Kobayashi M; Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan. masaki@pharm.hokudai.ac.jp.; Faculty of Pharmaceutical Sciences, Education Research Center for Clinical Pharmacy, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan. masaki@pharm.hokudai.ac.jp.
Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Sep; Vol. 30 (9), pp. 1757-1763. Date of Electronic Publication: 2025 Jul 07.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1437-7772
DOI:10.1007/s10147-025-02810-5